Navigation Links
Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
Date:12/8/2012

umulative toxicity or long-term safety concerns with a median follow-up of 16 months for treated patients.

Study Methodology and Results

116 CLL patients were enrolled in the study in a series of treatment cohorts, which included patients who were never treated (treatment-nave); those who had received two or more prior therapies (relapsed/refractory); those who had relapsed within two years of treatment (high-risk); and those over age 65. Two oral dosing regimens (420 mg or 840 mg) of ibrutinib were used daily. The primary goal of the study was to determine the safety of the low and high doses. Secondary objectives included efficacy, measures of the intensity of the drug's effect in the body and the long-term safety of administering continuously until relapse.

The majority of adverse effects were diarrhea (54%), fatigue (29%), upper respiratory tract infection (29%), rash (28%), nausea (26%) and arthralgias (25%). Hematologic toxicity ≥ Gr 3 was relatively infrequent. There was no evidence of cumulative toxicity or long-term safety concerns with a median follow-up of 16 months. Estimated 22 month progression free survival for the 85 relapsed or refractory and high-risk patients was 76 percent and 96 percent for treatment-nave patients. Estimated 22 month overall survival for the 85 relapsed or refractory patients and high-risk patients was 85 percent and 96 percent for treatment-nave patients. Funding from Pharmacyclics, Inc., supports this clinical trial.


'/>"/>

Contact: Liz Bryan, Spectrum
lbryan@spectrumscience.com
443-506-1931
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. EzCheckPrinting Updated with New Category Feature to Simplify Check Printing and Tax Reporting
2. Winning the battle against leukaemia: Positive early results in clinical trial for DNA vaccine
3. Pure Cocoa Powder, the Key Ingredient in Dark Chocolate and Found in Diabetes Support Supplements has been Clinically Proven to Reduce Cardiovascular Risk
4. USC Norris cancer research ranks among top clinical advances for 2012
5. American Society of Clinical Oncology issues annual report on state of clinical cancer science
6. Clinical trial at GHSU Cancer Center targets advanced prostate cancer
7. Study finds link between access to online health information and use of clinical services
8. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
9. Molecular portraits of tumours match patients with trials in everyday clinical practice
10. New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
11. Spread of human melanoma cells in mice correlates with clinical outcomes in patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... World Breast-Feeding ... to ensure their children have the nutrition required to grow into healthy adults. ... discount cards for many prescription pre-natal vitamins. , Folic Acid , Arguably one ...
(Date:7/29/2015)... (PRWEB) , ... July 30, 2015 , ... Drs. Hamstead ... doctors decided to add massage therapy to the offerings in the clinic; massage therapy ... spine. , Massage therapist Crystal Gaines has joined AlignLife of Simpsonville to work ...
(Date:7/29/2015)... ... 29, 2015 , ... If you’re a fan of Vietnamese banh mi sandwiches ... the Orange County Register , more than 465,000 pounds of mislabeled meat has ... does not mention any reported illnesses that have been connected to problems reportedly spotted ...
(Date:7/29/2015)... ... July 29, 2015 , ... In ... help with the problems of substance abuse that face today’s society, A Forever ... to come to their rehabilitation center. The facility, located in Southwest Michigan hosted ...
(Date:7/29/2015)... ... July 29, 2015 , ... VideoLink , ... Medical Center, located in New York, NY, selected the ReadyCam on-site video studio ... and scientists to immediately access worldwide TV and cable news networks and participate ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 3Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3
... disease among those vaccinated were no higher than in ... -- Rates of a rare neurodegenerative disease, Guillain-Barre syndrome, ... were no higher than among the general population, new ... noted after widespread swine flu vaccination in 1976, researchers ...
... ... ... 2,600 people is being sent to Mexico after an earthquake rocked the country last week. , ... 25,000 people have been affected by the earthquake with the worse damage in rural areas south ...
... 1871, Charles Darwin sparked debate that continues today when ... sexual selection. Sexual selection is Darwin,s theory that certain ... in competition among individuals for access to preferred mates ... to attract mates. Now, in a much expanded update ...
... ... ... After building a global leadership position developing mercury-free clean energy UV-LED solutions for an ... finalist for the 2010 TechAmerica Oregon Technology Awards. The award winners will be announced ...
... no social fear and appear open, friendly to all, ... -- Children with a rare condition called Williams syndrome ... prejudice, a new study shows. , The finding suggests ... racial stereotyping. , French and German researchers examined the ...
... grant from the Agency for Healthcare Research and Quality ... the comparative effectiveness of positron emission tomography (PET) and ... on the diagnosis and management of cancer patients, but ... , "Comparative effectiveness research is essential to the future ...
Cached Medicine News:Health News:Guillain-Barre Syndrome Very Rare After H1N1 Vaccine 2Health News:Guillain-Barre Syndrome Very Rare After H1N1 Vaccine 3Health News:ShelterBox Aid en route to Mexico Following Earthquake 2Health News:ShelterBox Aid en route to Mexico Following Earthquake 3Health News:Darwin was right 2Health News:Darwin was right 3Health News:Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards 2Health News:Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards 3Health News:Kids With Rare Condition Lack Racial Prejudice 2Health News:SNM receives grant from AHRQ for comparative effectiveness research 2
(Date:7/29/2015)... July 29, 2015 WuXi PharmaTech (Cayman) Inc. ... and technology platform company serving the pharmaceutical, biotechnology and ... and the United States ... for the second-quarter of 2015 after the New York ... will be Friday morning, August 14, 2015 Shanghai time). ...
(Date:7/29/2015)... SAN DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... ended June 30, 2015. For the second quarter of 2015, the ... per share, compared to a net loss of $13.4 million, or ... the six months ended June 30, 2015, the Company reported a ... compared to net loss of $25.2 million, or $0.35 loss per ...
(Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2
... Nov. 1, 2011 Cambrex Corporation (NYSE: ... will be released on Thursday, November 3, 2011 after ... host a conference call to discuss the third quarter ... Friday, November 4, 2011 at 8:30 a.m. Eastern Time ...
... Inc. (NASDAQ: HSIC ), the largest provider ... reported record financial results for the quarter ended September ... and related profits were lower this quarter than in ... meaningful commentary the Company will be discussing results including ...
Cached Medicine Technology:Henry Schein Reports Record Third Quarter Results 2Henry Schein Reports Record Third Quarter Results 3Henry Schein Reports Record Third Quarter Results 4Henry Schein Reports Record Third Quarter Results 5Henry Schein Reports Record Third Quarter Results 6Henry Schein Reports Record Third Quarter Results 7Henry Schein Reports Record Third Quarter Results 8Henry Schein Reports Record Third Quarter Results 9Henry Schein Reports Record Third Quarter Results 10Henry Schein Reports Record Third Quarter Results 11
Pocket-sized instrument with 2.5X magnification....
Durable, simple and easy to use. Lightweight, base can detach and be used as a penlight....
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 3.5V xenon ... of examination area. Used ...
Medicine Products: